title: The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric kidney transplant recipients.
abstract: Advances in anti-HLA antibody characterization have had a major impact on kidney transplantation. Comprehensive characterization of DSA has improved protocols for allosensitized transplant candidates, increasing access to acceptable donors. Sensitive and specific solid phase antibody detection assays have given important insight into the clinical characteristics of antibody-mediated allograft injury, resulting in the development of a classification system for acute AMR. In addition, important insights into the nature of chronic antibody-mediated allograft rejection have been achieved as a result of improvements in DSA characterization. Finally, assays initially developed as tools to detect DSA in the clinical setting have been employed in innovative research protocols, allowing the investigation of new therapeutic approaches.
authors.affiliation: Von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA. poncelet.monica@mayo.edu
authors.forename: James M
authors.initials: JM
authors.lastname: Gloor
mesh_terms: D000906:Antibodies / Q000737:chemistry / Q000276:immunology*; D002648:Child; D006084:Graft Rejection / Q000276:immunology; D006680:HLA Antigens / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods*; D010372:Pediatrics / Q000379:methods; D051437:Renal Insufficiency / Q000276:immunology / Q000628:therapy*; D015203:Reproducibility of Results; D012306:Risk; D013997:Time Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000379:methods; D014184:Transplantation, Homologous / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D006680:HLA Antigens